Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entonox for pain, anxiety, and radial artery spasm during transradial coronary angiography
IRCT20201028049181N5Phase 3Recruiting
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-blind trial of nitrous oxide + oxygen in pain, anxiety disorder and radial artery spasm (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Reduced risk of radial spasm or vasovagal symptoms, Hemodynamic stability and 1 more. Started Sep 2026; status: recruiting.
02
Drugs
nitrous oxide + oxygen
03
Conditions
painanxiety disorderradial artery spasm
Beyond the preview
Go deeper on IRCT20201028049181N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049181N5.